In a major personnel shift, UnitedHealth Group (NYSE:UNH) announced this week that Larry Renfro, CEO of its subsidiary Optum, will step away from the corner office to become managing partner of Optum Ventures and its expanded $600 million investment fund.
Ex-GlaxoSmithKline (NYSE:GSK) chief executive, Andrew Witty, will take Renfro’s place as CEO of Optum on July 1, the company announced March 13. Witty has been a member of UnitedHealth’s board since August of 2017.
DeviceTalks Minnesota's leadership track is designed to provide attendees with insights on topics such as:
Use code SAVE15 to save 15%!